Efficacy and Safety of LM-302 Combined With Gemcitabine CLDN 18.2 Positive Unresectable Locally Advanced or Metastatic Pancreatic Cancer
Clinical trial NCT07108504 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07108504
- Sponsor
- Shanghai Zhongshan Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-10
- Primary completion
- 2026-08-10
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.